CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 220 enrolled
Drug / intervention
Level 1: (provide site-specifi information) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01002456
NCT01002456N/ACompleted
CompareCT.gov

Beta-Blockers in Heart Failure: Pharmacy-level Intervention Comparison

US Department of Veterans Affairs·interventional·Posted Oct 27, 2009·Updated Apr 28, 2015

In Brief

A clinical study evaluating Level 1: (provide site-specifi information) and Level 2 (Provide site- and patient-specific information) for Heart Failure. Completed, enrolled 220 participants across 1 site.

Detailed Summary

The overall objective of the proposed pilot study is to begin evaluation of two methods for promoting adherence to guidelines for beta-blocker therapy in heart failure. The design includes site level baseline measurement, feedback, remeasurement after six months, and randomized (by site) comparison samples. The setting is VA sites, with intervention directed at the pharmacy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 27, 2009
Enrollment StartOct 1, 2009
Primary CompletionJun 1, 2011
Study CompletionOct 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 16.7 years ago

Interventions

Level 1: (provide site-specifi information)other

provide site-specific information on non-adherence to guideline

Level 2 (Provide site- and patient-specific information)other

provide site-specific information on non-adherence to guideline as well as list of patients with non-adherent prescriptions